Welcome to the Fusion for Medical Radionuclides Event!
We are pleased to invite experts from academia, public and private fusion organisations, public health organisations, pharma industry, as well as stakeholders from government bodies to the Fusion for Medical Radionuclides Event, which will take place on the Wednesday 24th September our Culham Campus!
The UK's capacity to produce medical radionuclides is currently limited, which can make treatments in nuclear medicine at-risk. This is further influenced by growing markets and existing international reactors that are aging and undergoing frequent periods of maintenance. A number of projects are underway across the UK to develop methods of domestic production. One such method may be through the emergence and growth of fusion technology; where applications beyond typical power production facilities can be explored. For example, the high energy neutrons available from deuterium-tritium fusion may open up certain production routes of novel medical radionuclides that may currently be unavailable with existing routes.
The UKAEA Innovation team is organising a one-day event to discuss and explore how fusion technology could help address the current and future demands for medical radionuclides, in the UK and beyond, with talks from experts and plenty of time for networking.
The event presents an opportunity to explore how fusion technology could enable innovation in global healthcare, in critical areas such as targeted cancer therapy, precise diagnostics and more!
Interested in showcasing your work? We have space for up to 10 posters during the Networking & Poster Session. Poster presenters are expected to bring their own posters and be available to engage with attendees and stakeholders during the session. You can book your space for a posters at the registration form.
Registration
To register for the event, please complete the registration form by clicking on the "Book a Ticket" tab on the left-hand side of the page.
If you're not already logged into Indico (the web-based event management system hosting this site), you’ll be automatically redirected to the login or account creation page before you can proceed.
Who should register?
This event welcomes professionals and stakeholders from a wide range of sectors, including: academia; public and private fusion research organisations; public health institutions; pharmaceutical companies and government bodies.
If you're interested in exploring how fusion technology can contribute to meeting the growing demand for medical radionuclides, both now and in the future, this event is for you.
Due to a limited number of tickets, we may need to restrict the number of participants per organisation. Tickets will be allocated on a first-come, first-served basis, in accordance with the eligibility criteria above.
Please note before registering
By booking a ticket, you are registering your interest in attending the event. The Innovation team will review all registrations in line with the criteria outlined above, and you will receive an email shortly confirming whether or not your place has been secured.
We kindly ask that you only register if you are confident you can attend. This helps us manage resources responsibly and ensure that spaces are used effectively.
